アルファブロッカーの世界市場動向・分析2018-2025

【英語タイトル】Global Alpha Blockers Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00334)・商品コード:QYR8D00334
・発行会社(調査会社):QYResearch
・発行日:2018年10月31日(※2024年版があります。お問い合わせください)
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、アルファブロッカーの世界市場について調査・分析し、種類別には、非選択的拮抗薬、選択的拮抗薬に、用途別には、高血圧、レイノー病、勃起機能不全に区分してまとめました。調査対象企業は、Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical等です。

・レポートの概要
・グローバル成長トレンド
・アルファブロッカーの世界市場規模
・アルファブロッカーの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別アルファブロッカーの価格動向
・アルファブロッカーの種類別市場規模(非選択的拮抗薬、選択的拮抗薬)
・アルファブロッカーの用途別市場規模(高血圧、レイノー病、勃起機能不全)
・アルファブロッカーの北米市場(アメリカ、カナダ、メキシコ)
・アルファブロッカーのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・アルファブロッカーのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アルファブロッカーの中南米市場(ブラジル等)
・アルファブロッカーの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・アルファブロッカーの市場規模予測
・アルファブロッカーの種類別市場予測2018-2025(非選択的拮抗薬、選択的拮抗薬)
・アルファブロッカーの用途別市場予測2018-2025(高血圧、レイノー病、勃起機能不全)
・アルファブロッカーの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・アルファブロッカーのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・アルファブロッカーのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アルファブロッカーの中南米市場予測2018-2025(ブラジル等)
・アルファブロッカーの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).In 2018, the global Alpha Blockers market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Alpha Blockers.

This study researches the market size of Alpha Blockers, presents the global Alpha Blockers sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Alpha Blockers in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Alpha Blockers for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly and Company
Sanofi SA
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Segment by Product Type
Non-selective Antagonists
Selective Antagonists

Market Segment by Application
Hypertension
Raynaud’s Disease
Erectile Dysfunction

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Alpha Blockers status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Alpha Blockers manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alpha Blockers are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Alpha Blockers Market Size Growth Rate by Type
1.3.2 Non-selective Antagonists
1.3.3 Selective Antagonists
1.4 Market Segment by Application
1.4.1 Global Alpha Blockers Market Share by Application (2018-2025)
1.4.2 Hypertension
1.4.3 Raynaud’s Disease
1.4.4 Erectile Dysfunction
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Alpha Blockers Market Size
2.1.1 Global Alpha Blockers Revenue 2013-2025
2.1.2 Global Alpha Blockers Sales 2013-2025
2.2 Alpha Blockers Growth Rate by Regions
2.2.1 Global Alpha Blockers Sales by Regions 2013-2018
2.2.2 Global Alpha Blockers Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Alpha Blockers Sales by Manufacturers
3.1.1 Alpha Blockers Sales by Manufacturers 2013-2018
3.1.2 Alpha Blockers Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Alpha Blockers Revenue by Manufacturers (2013-2018)
3.2.2 Alpha Blockers Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Alpha Blockers Market Concentration Ratio (CR5 and HHI)
3.3 Alpha Blockers Price by Manufacturers
3.4 Key Manufacturers Alpha Blockers Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Alpha Blockers Market
3.6 Key Manufacturers Alpha Blockers Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Non-selective Antagonists Sales and Revenue (2013-2018)
4.1.2 Selective Antagonists Sales and Revenue (2013-2018)
4.2 Global Alpha Blockers Sales Market Share by Type
4.3 Global Alpha Blockers Revenue Market Share by Type
4.4 Alpha Blockers Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Alpha Blockers Sales by Application

6 North America
6.1 North America Alpha Blockers Breakdown Data by Company
6.2 North America Alpha Blockers Breakdown Data by Type
6.3 North America Alpha Blockers Breakdown Data by Application
6.4 North America Alpha Blockers Breakdown Data by Countries
6.4.1 North America Alpha Blockers Sales by Countries
6.4.2 North America Alpha Blockers Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Alpha Blockers Breakdown Data by Company
7.2 Europe Alpha Blockers Breakdown Data by Type
7.3 Europe Alpha Blockers Breakdown Data by Application
7.4 Europe Alpha Blockers Breakdown Data by Countries
7.4.1 Europe Alpha Blockers Sales by Countries
7.4.2 Europe Alpha Blockers Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Alpha Blockers Breakdown Data by Company
8.2 Asia Pacific Alpha Blockers Breakdown Data by Type
8.3 Asia Pacific Alpha Blockers Breakdown Data by Application
8.4 Asia Pacific Alpha Blockers Breakdown Data by Countries
8.4.1 Asia Pacific Alpha Blockers Sales by Countries
8.4.2 Asia Pacific Alpha Blockers Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Alpha Blockers Breakdown Data by Company
9.2 Central & South America Alpha Blockers Breakdown Data by Type
9.3 Central & South America Alpha Blockers Breakdown Data by Application
9.4 Central & South America Alpha Blockers Breakdown Data by Countries
9.4.1 Central & South America Alpha Blockers Sales by Countries
9.4.2 Central & South America Alpha Blockers Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Alpha Blockers Breakdown Data by Type
10.2 Middle East and Africa Alpha Blockers Breakdown Data by Application
10.3 Middle East and Africa Alpha Blockers Breakdown Data by Countries
10.3.1 Middle East and Africa Alpha Blockers Sales by Countries
10.3.2 Middle East and Africa Alpha Blockers Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Alpha Blockers
11.1.4 Alpha Blockers Product Introduction
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Alpha Blockers
11.2.4 Alpha Blockers Product Introduction
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Alpha Blockers
11.3.4 Alpha Blockers Product Introduction
11.3.5 Merck Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Alpha Blockers
11.4.4 Alpha Blockers Product Introduction
11.4.5 Astra Zeneca Recent Development
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Alpha Blockers
11.5.4 Alpha Blockers Product Introduction
11.5.5 Jhonson and Johnson Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Alpha Blockers
11.6.4 Alpha Blockers Product Introduction
11.6.5 Eli Lilly and Company Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Alpha Blockers
11.7.4 Alpha Blockers Product Introduction
11.7.5 Sanofi SA Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Alpha Blockers
11.8.4 Alpha Blockers Product Introduction
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Alpha Blockers
11.9.4 Alpha Blockers Product Introduction
11.9.5 Bayer Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Alpha Blockers
11.10.4 Alpha Blockers Product Introduction
11.10.5 GSK Recent Development
11.11 Teva Pharmaceutical

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Alpha Blockers Sales Channels
12.2.2 Alpha Blockers Distributors
12.3 Alpha Blockers Customers

13 Market Forecast
13.1 Global Alpha Blockers Sales and Revenue Forecast 2018-2025
13.2 Global Alpha Blockers Sales Forecast by Type
13.3 Global Alpha Blockers Sales Forecast by Application
13.4 Alpha Blockers Forecast by Regions
13.4.1 Global Alpha Blockers Sales Forecast by Regions 2018-2025
13.4.2 Global Alpha Blockers Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Alpha Blockers Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Alpha Blockers Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Alpha Blockers Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Alpha Blockers Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Alpha Blockers Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Alpha Blockers Product Picture
Table Alpha Blockers Key Market Segments
Table Major Manufacturers Alpha Blockers Covered in This Report
Table Global Alpha Blockers Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Alpha Blockers Sales Market Shar by Type 2013-2025
Figure Non-selective Antagonists Figures
Table Major Manufacturers of Non-selective Antagonists
Figure Selective Antagonists Figures
Table Major Manufacturers of Selective Antagonists
Table Global Alpha Blockers Market Share by Application 2018-2025 (K Units)
Figure Hypertension Use Case
Figure Raynaud's Disease Use Case
Figure Erectile Dysfunction Use Case
Figure Alpha Blockers Report Years Considered
Figure Global Alpha Blockers Market Size 2013-2025 (Million US$)
Figure Global Alpha Blockers Sales 2013-2018 (K Units)
Table Global Alpha Blockers Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Alpha Blockers Sales by Regions 2013-2018 (K Units)
Table Global Alpha Blockers Sales Market Share by Regions 2013-2018
Figure Global Alpha Blockers Sales Market Share by Regions 2013-2018
Figure Global Alpha Blockers Sales Market Share by Regions in 2018
Table Global Alpha Blockers Revenue by Regions 2013-2018 (Million US$)
Table Global Alpha Blockers Revenue Market Share by Regions 2013-2018
Figure Global Alpha Blockers Revenue Market Share by Regions 2013-2018
Figure Global Alpha Blockers Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Alpha Blockers Sales by Manufacturers (2013-2018) (K Units)
Table Global Alpha Blockers Sales Share by Manufacturers (2013-2018)
Figure Global Alpha Blockers Sales Share by Manufacturers in 2018
Table Alpha Blockers Revenue by Manufacturers (2013-2018) (Million USD)
Table Alpha Blockers Revenue Share by Manufacturers (2013-2018)
Figure Alpha Blockers Value Share by Manufacturers in 2018
Table Global Alpha Blockers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Alpha Blockers Price (2013-2018) (USD/Unit)
Table Key Manufacturers Alpha Blockers Plants/Factories Distribution
Table Key Manufacturers Alpha Blockers Area Served
Table Date of Key Manufacturers Enter into Alpha Blockers Market
Table Key Manufacturers Alpha Blockers Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-selective Antagonists Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Selective Antagonists Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Alpha Blockers Sales by Type (2013-2018) (K Units)
Table Global Alpha Blockers Sales Share by Type (2013-2018)
Figure Global Alpha Blockers Sales Market Share by Type (2013-2018)
Figure Global Alpha Blockers Sales Market Share by Type in 2017
Table Global Alpha Blockers Revenue by Type (2013-2018) (Million US$)
Table Global Alpha Blockers Revenue Share by Type (2013-2018)
Figure Global Alpha Blockers Revenue Market Share by Type (2013-2018)
Figure Global Alpha Blockers Revenue Market Share by Type in 2017
Table Alpha Blockers Price by Type 2013-2018 (USD/Unit)
Table Global Alpha Blockers Sales by Application (2013-2018) (K Units)
Table Global Alpha Blockers Sales Share by Application (2013-2018)
Figure Global Sales Alpha Blockers Market Share by Application (2013-2018)
Figure Global Sales Alpha Blockers Market Share by Application in 2017
Figure North America Alpha Blockers Sales Growth Rate 2013-2018 (K Units)
Figure North America Alpha Blockers Revenue Growth Rate 2013-2018 (Million US$)
Table North America Alpha Blockers Sales by Company (2013-2018) (K Units)
Table North America Alpha Blockers Sales Market Share by Company (2013-2018)
Figure North America Alpha Blockers Sales Market Share by Company in 2018
Table North America Alpha Blockers Sales by Type (2013-2018) (K Units)
Table North America Alpha Blockers Sales Market Share by Type (2013-2018)
Figure North America Alpha Blockers Market Share by Type in 2018
Table North America Alpha Blockers Sales by Application (2013-2018) (K Units)
Table North America Alpha Blockers Sales Market Share by Application (2013-2018)
Figure North America Alpha Blockers Market Share by Application in 2018
Table North America Alpha Blockers Sales by Countries (2013-2018) (K Units)
Table North America Alpha Blockers Sales Market Share by Countries (2013-2018)
Figure 2017 North America Alpha Blockers Sales Market Share by Countries
Table North America Alpha Blockers Revenue by Countries (2013-2018) (Million US$)
Table North America Alpha Blockers Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Alpha Blockers Revenue Market Share by Countries
Figure United States Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Canada Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Europe Alpha Blockers Sales Growth Rate 2013-2018 (K Units)
Figure Europe Alpha Blockers Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Alpha Blockers Sales by Company (2013-2018) (K Units)
Table Europe Alpha Blockers Sales Market Share by Company (2013-2018)
Figure Europe Alpha Blockers Sales Market Share by Company in 2018
Table Europe Alpha Blockers Sales by Type (2013-2018) (K Units)
Table Europe Alpha Blockers Sales Market Share by Type (2013-2018)
Figure 2017 Europe Alpha Blockers Market Share by Type
Table Europe Alpha Blockers Sales by Application (2013-2018) (K Units)
Table Europe Alpha Blockers Sales Market Share by Application (2013-2018)
Figure 2017 Europe Alpha Blockers Market Share by Application
Table Europe Alpha Blockers Sales by Countries (2013-2018) (K Units)
Table Europe Alpha Blockers Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Alpha Blockers Sales Market Share by Countries
Table Europe Alpha Blockers Revenue by Countries (2013-2018) (Million US$)
Table Europe Alpha Blockers Revenue Market Share by Countries (2013-2018)
Figure Europe Alpha Blockers Revenue Market Share by Countries in 2018
Figure Germany Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure France Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure UK Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Italy Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Russia Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Alpha Blockers Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Alpha Blockers Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Alpha Blockers Sales by Company (2013-2018) (K Units)
Table Asia Pacific Alpha Blockers Sales Market Share by Company (2013-2018)
Figure Asia Pacific Alpha Blockers Sales Market Share by Company in 2018
Table Asia Pacific Alpha Blockers Sales by Type (2013-2018) (K Units)
Table Asia Pacific Alpha Blockers Sales Market Share by Type (2013-2018)
Figure Asia Pacific Alpha Blockers Market Share by Type in 2018
Table Asia Pacific Alpha Blockers Sales by Application (2013-2018) (K Units)
Table Asia Pacific Alpha Blockers Sales Market Share by Application (2013-2018)
Figure Asia Pacific Alpha Blockers Market Share by Application in 2018
Table Asia Pacific Alpha Blockers Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Alpha Blockers Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Alpha Blockers Sales Market Share by Countries
Table Asia Pacific Alpha Blockers Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Alpha Blockers Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Alpha Blockers Revenue Market Share by Countries
Figure China Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure China Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Japan Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Korea Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure India Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure India Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Australia Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Alpha Blockers Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Alpha Blockers Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Alpha Blockers Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Alpha Blockers Sales by Company (2013-2018) (K Units)
Table Central & South America Alpha Blockers Sales Market Share by Company (2013-2018)
Figure Central & South America Alpha Blockers Sales Market Share by Company in 2018
Table Central & South America Alpha Blockers Sales by Type (2013-2018) (K Units)
Table Central & South America Alpha Blockers Sales Market Share by Type (2013-2018)
Figure Central & South America Alpha Blockers Market Share by Type in 2018
Table Central & South America Alpha Blockers Sales by Application (2013-2018) (K Units)
Table Central & South America Alpha Blockers Sales Market Share by Application (2013-2018)
Figure Central & South America Alpha Blockers Market Share by Application in 2018
Table Central & South America Alpha Blockers Sales by Countries (2013-2018) (K Units)
Table Central & South America Alpha Blockers Sales Market Share by Countries (2013-2018)
Figure Central & South America Alpha Blockers Sales Market Share by Countries in 2018
Table Central & South America Alpha Blockers Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Alpha Blockers Revenue Market Share by Countries (2013-2018)
Figure Central & South America Alpha Blockers Revenue Market Share by Countries in 2018
Figure Brazil Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Alpha Blockers Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Alpha Blockers Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Alpha Blockers Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Alpha Blockers Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Alpha Blockers Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Alpha Blockers Market Share by Type
Table Middle East and Africa Alpha Blockers Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Alpha Blockers Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Alpha Blockers Market Share by Application
Table Middle East and Africa Alpha Blockers Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Alpha Blockers Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Alpha Blockers Sales Market Share by Countries
Table Middle East and Africa Alpha Blockers Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Alpha Blockers Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Alpha Blockers Revenue Market Share by Countries
Figure GCC Countries Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Alpha Blockers Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Alpha Blockers Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Alpha Blockers Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Alpha Blockers Revenue Growth Rate (2013-2018) (K Units)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Alpha Blockers Sales Growth Rate (2013-2018)
Table Pfizer Alpha Blockers Sales Market Share in Global Market
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis Alpha Blockers Sales Growth Rate (2013-2018)
Table Novartis Alpha Blockers Sales Market Share in Global Market
Table Novartis Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Alpha Blockers Sales Growth Rate (2013-2018)
Table Merck Alpha Blockers Sales Market Share in Global Market
Table Merck Recent Development
Table Astra Zeneca Company Details
Table Astra Zeneca Description and Business Overview
Table Astra Zeneca Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Astra Zeneca Alpha Blockers Sales Growth Rate (2013-2018)
Table Astra Zeneca Alpha Blockers Sales Market Share in Global Market
Table Astra Zeneca Recent Development
Table Jhonson and Johnson Company Details
Table Jhonson and Johnson Description and Business Overview
Table Jhonson and Johnson Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Jhonson and Johnson Alpha Blockers Sales Growth Rate (2013-2018)
Table Jhonson and Johnson Alpha Blockers Sales Market Share in Global Market
Table Jhonson and Johnson Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eli Lilly and Company Alpha Blockers Sales Growth Rate (2013-2018)
Table Eli Lilly and Company Alpha Blockers Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Sanofi SA Company Details
Table Sanofi SA Description and Business Overview
Table Sanofi SA Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi SA Alpha Blockers Sales Growth Rate (2013-2018)
Table Sanofi SA Alpha Blockers Sales Market Share in Global Market
Table Sanofi SA Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bristol-Myers Squibb Alpha Blockers Sales Growth Rate (2013-2018)
Table Bristol-Myers Squibb Alpha Blockers Sales Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Alpha Blockers Sales Growth Rate (2013-2018)
Table Bayer Alpha Blockers Sales Market Share in Global Market
Table Bayer Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Alpha Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GSK Alpha Blockers Sales Growth Rate (2013-2018)
Table GSK Alpha Blockers Sales Market Share in Global Market
Table GSK Recent Development
Table Teva Pharmaceutical Company Details
Figure Alpha Blockers Value Chain
Table Alpha Blockers Distributors List
Table Alpha Blockers Customers List
Table Global Alpha Blockers Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Global Alpha Blockers Revenue Forecast 2018-2025 (Million US$)
Table Global Alpha Blockers Sales Forecast by Type 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Forecast by Type 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Market Share Forecast by Type 2018-2025
Table Global Alpha Blockers Sales Forecast by Application 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Forecast by Application 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Market Share Forecast by Application 2018-2025
Table Global Alpha Blockers Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Alpha Blockers Sales Market Share Forecast by Regions 2018-2025
Table Global Alpha Blockers Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Alpha Blockers Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Alpha Blockers Revenue Market Share Forecast by Regions 2018-2025
Table North America Alpha Blockers Sales Forecast by Countries 2018-2025 (K Units)
Table North America Alpha Blockers Sales Market Share Forecast by Countries 2018-2025
Table North America Alpha Blockers Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Alpha Blockers Revenue Market Share Forecast by Countries 2018-2025
Figure United States Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Canada Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure MexicoAlpha Blockers Sales Forecast 2018-2025 (K Units)
Table Europe Alpha Blockers Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Alpha Blockers Sales Market Share Forecast by Countries 2018-2025
Table Europe Alpha Blockers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Alpha Blockers Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure France Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure UK Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Italy Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Russia Alpha Blockers Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Alpha Blockers Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Alpha Blockers Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Alpha Blockers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Alpha Blockers Revenue Market Share Forecast by Countries 2018-2025
Figure China Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Japan Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Korea Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure India Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Australia Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Indonesia Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Thailand Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Malaysia Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Philippines Alpha Blockers Sales Forecast 2018-2025 (K Units)
Figure Vietnam Alpha Blockers Sales Forecast 2018-2025 (K Units)
Table Central & South America Alpha Blockers Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Alpha Blockers Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Alpha Blockers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Alpha Blockers Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Alpha Blockers Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Alpha Blockers Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Alpha Blockers Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Alpha Blockers Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Alpha Blockers Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Alpha Blockers Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Alpha Blockers Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Alpha Blockers Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical

★調査レポート[アルファブロッカーの世界市場動向・分析2018-2025] (コード:QYR8D00334)販売に関する免責事項を必ずご確認ください。
★調査レポート[アルファブロッカーの世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆